SION
SION
NASDAQ · Biotechnology

Sionna Therapeutics Inc

$5.96
-1.22 (-16.99%)
As of Sep 20, 10:10 PM ET ·
Analyst Consensus
Hold
17
Analysts
High
Coverage
Buy 6 35%
Hold 11 65%
Sell 0 0%
Price Target
Analyst Price Target +320.5% upside
Low Target $14.18
Average Target $25.06
High Target $26.23
Current Price $5.96
Current
$5.96
Target
$25.06
$14.18 $25.06 avg $26.23
Scenario Analysis
Bear Case
$14.18
137.9%
Low target
Base Case
$25.06
+320.5%
Avg target
Bull Case
$26.23
+340.1%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$54.97
-89.2% from high
52-Week Low
$4.01
+48.6% from low
Target vs 52W High
$25.06
-54.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.9%
AMGN
Amgen Inc
Hold 43 47% $190.87 -53.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.6%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -14.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
Hold 30 37% $149.45 -18.1%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -63.4%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -40.8%